Oral antibiotics for treating bone and joint infections in children
Official title: Initial Oral Antibiotics for Bone and Joint Infections in Children: A Prospective Nationwide Real-world Effectiveness Study in Denmark
Run by Copenhagen University Hospital, Rigshospitalet · NCT06827496 · Data updated 2026-11-12
This study is testing if giving oral antibiotics first can effectively and safely treat uncomplicated bone and joint infections in children and teens aged 3 months to 17 years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Months to 17 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen Ø) |
| Status | Recruiting |
| Started | November 15, 2024 |
| Main results expected | November 15, 2026 |
| Study ends | May 2027 |
| Registry record updated | April 9, 2025 |
| Trial ID | NCT06827496 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents aged 3 months to 17 years with uncomplicated bone and joint infections who are treated with initial oral antibiotics.
✕Probably not a fit
Patients with complicated bone and joint infections or those requiring intravenous antibiotic therapy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This nationwide, prospective, multicenter cohort study aims to evaluate the effectiveness and safety of initial oral antibiotic treatment for children and adolescents aged 3 months to 17 years with uncomplicated bone and joint infections. The study will compare real-world outcomes of these patients with those who received oral antibiotics in a previous randomized controlled trial. Conducted across 18 Pediatric Departments in Denmark, the study will include 100 participants treated with oral antibiotics from 2024 to 2026. The goal is to provide insights into the real-world application of oral antibiotics in this patient population.
Why it matters
Potential benefit: If successful, this study could provide evidence supporting the use of oral antibiotics as a safe and effective treatment option for children with uncomplicated bone and joint infections.
How similar studies have gone: Previous studies have shown that initial oral antibiotics can be non-inferior to intravenous antibiotics, but this study aims to further validate these findings in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Children and adolescents aged 3 months to 17 years with uncomplicated bone and joint infections treated with initial oral antibiotics. According to Danish Nationwide Guidelines (initiated in 2024), initial oral antibiotics are recommended to patients with no risk factors for complicated disease. Risk factors include for complicated disease include: 1. Severe illness or sepsis 2. Rapid symptom progression 3. Pronounced symptoms, including severe pain 4. Pronounced soft tissue involvement 5. Foreign material or post-surgical infection 6. Infection with a resistent or rare pathogen, e.g., Salmonella or MRSA 7. Severe comorbidity, including immunodeficiency Patients who have received intravenous antibiotic therapy for less than 24 h before oral antibiotics will be included
Where it's running
-
Rigshospitalet
Copenhagen Ø, Denmark Recruiting
Study contacts
- Study coordinator: Ulrikka Nygaard, Ass Professor, PhD, MD, MPhil
- Email: Ulrikka.Nygaard@regionh.dk
- Phone: +45 35459761
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral antibiotics for treating bone and joint infections in children
This study tests if giving only oral antibiotics can effectively treat bone and joint infections in children, compared to the usual method that starts with IV antibiotics.
-
Trimethoprim-sulfamethoxazole versus clindamycin for children with invasive MRSA infections
This will see if trimethoprim-sulfamethoxazole works as well as clindamycin to treat invasive MRSA infections in children aged 60 days to 18 years.
-
Using alpha-defensin and synovial proteins to diagnose pediatric septic arthritis
This study is testing if certain proteins in joint fluid can help doctors better diagnose septic arthritis in children who might have joint infections.
-
High-resolution infrared imaging to detect bone, joint and soft-tissue infections in children
We will test whether a 10-second high-resolution infrared thermal video can help detect bone, joint, or soft-tissue infections in children up to 15 years old.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Comparing two types of spacers for treating knee joint infections
This study is testing which type of spacer works better for treating knee joint infections in patients who have had knee replacement surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.